Comparison between Razorpay Software IPO and Ujin Pharma IPO.
Razorpay Software IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Ujin Pharma IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Razorpay Software IPO is whereas the issue size of the Ujin Pharma IPO is up to ₹0.00 Cr. The final issue price of Razorpay Software IPO is and of Ujin Pharma IPO is .
| Razorpay Software IPO | Ujin Pharma IPO | |
|---|---|---|
| Face Value | ₹10 per share | |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 1,18,69,100 shares | |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | |
| OFS Issue Size | 72,82,300 shares | |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | |
| Issue Size Total | 0 shares | 1,91,51,400 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr |
Razorpay Software IPO opens on , while Ujin Pharma IPO opens on . The closing date of Razorpay Software IPO and Ujin Pharma IPO is , and , respectively.
Razorpay Software IPO P/E ratio is , as compared to Ujin Pharma IPO P/E ratio of .
| Razorpay Software IPO | Ujin Pharma IPO | ||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 98.50 | ||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | |||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | |||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 12.15 | ||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 12.54 | ||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.57 | ||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.60 | ||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 11.87 | ||||||||||||||||||||||||||||||||||||||||||||||
In the Razorpay Software IPO Retail Individual Investors (RII) are offered while in Ujin Pharma IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Razorpay Software IPO and 0 shares in Ujin Pharma IPO.
| Razorpay Software IPO | Ujin Pharma IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | |
| Market Maker Reservation | 0 shares | |
| QIB | 0 shares | |
| NII | 0 shares | |
| RII | 0 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 0 shares |
Razorpay Software IPO subscribed in total, whereas Ujin Pharma IPO subscribed .
